Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 11, 2006, Pages 2160-2166

  Sutcliffe, Siobhan ^a   Giovannucci, Edward ^d   De Marzo, Angelo M ^b,c   Leitzmann, Michael F ^e   Willett, Walter C ^d   Platz, Elizabeth A ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FOLLOW UP; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATITIS; QUESTIONNAIRE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS;

ADULT; AGE FACTORS; AGED; FOLLOW-UP STUDIES; GONORRHEA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; PROSTATITIS; QUESTIONNAIRES; RISK; RISK FACTORS; SYPHILIS;

EID: 33845318568     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0913     Document Type: Article

References (39)

1. Ravich A, Ravich RA. Prophylaxis of cancer of the prostate, penis, and cervix by circumcision. N Y State J Med 1950;50:1519-20.
2. Dennis LK, Dawson DV. Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 2002;13:72-9.
3. Dennis LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and prostate cancer. Urology 2002;60:78-83.
4. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-92.
5. Adami HO, Kuper H, Andersson SO, Bergstrom R, Dillner J. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2003;12:872-5.
6. Dillner J, Knekt P, Boman J, et al. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer 1998;75:564-7.
7. Rosenblatt KA, Wicklund KG, Stanford JL. Sexual factors and the risk of prostate cancer. Am J Epidemiol 2001;153:1152-8.
8. Lightfoot N, Conlon M, Krieger N, Sass-Kortsak A, Purdham J, Darlington G. Medical history, sexual, and maturational factors and prostate cancer risk. Ann Epidemiol 2004;14:655-62.
9. Roberts RO, Bergstralh EJ, Bass SE, Lieber MM, Jacobsen SJ. Prostatitis as a risk factor for prostate cancer. Epidemiology 2004;15:93-9.
10. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2004. Atlanta (GA): U.S. Department of Health and Human Services; 2005.
11. Hayes RB, Pottern LM, Strickler H, et al. Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer 2000;82:718-25.
12. Hiatt RA, Armstrong MA, Klatsky AL, Sidney S. Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control 1994;5:66-72.
13. Patel DA, Bock CH, Schwartz K, Wenzlaff AS, Demers RY, Severson RK. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case-control study in Wayne County, Michigan. Cancer Causes Control 2005;16:263-73.
14. Lees RE, Steele R, Wardle D. Arsenic, syphilis, and cancer of the prostate. J Epidemiol Community Health 1985;39:227-30.
15. Checkoway H, DiFerdinando G, Hulka BS, Mickey DD. Medical, life-style, and occupational risk factors for prostate cancer. Prostate 1987;10:79-88.
16. Mishina T, Watanabe H, Araki H, Nakao M. Epidemiological study of prostatic cancer by matched-pair analysis. Prostate 1985;6:423-36.
17. Wynder EL, Mabuchi K, Whitmore WF, Jr. Epidemiology of cancer of the prostate. Cancer 1971;28:344-60.
18. Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS, Trichopoulos D. Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer 1999;80:699-703.
19. Pelucchi C, Talamini R, Negri E, Franceschi S, La Vecchia C. Genital and urinary tract diseases and prostate cancer risk. Eur J Cancer Prev 2006;15:254-7.
20. Ilic M, Vlajinac H, Marinkovic J. Case-control study of risk factors for prostate cancer. Br J Cancer 1996;74:1682-6.
21. Heshmat MY, Kovi J, Herson J, Jones GW, Jackson MA. Epidemiologic association between gonorrhea and prostatic carcinoma. Urology 1975;6:457-60.
22. Baker LH, Mebust WK, Chin TD, Chapman AL, Hinthorn D, Towle D. The relationship of herpesvirus to carcinoma of the prostate. J Urol 1981;125:370-4.
23. Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 1988;57:326-31.
24. Sutcliffe S, Giovannucci E, De Marzo AM, Willett WC, Platz EA. Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms. Am J Epidemiol 2005;162:898-906.
25. Pelouze PS. Gonorrhea in the male and female: a book for practitioners. Philadelphia: W. B. Saunders Company; 1935.
26. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol 1998;159:1224-8.
27. Moon TD, Hagen L, Heisey DM. Urinary symptomatology in younger men. Urology 1997;50:700-3.
28. Daniels NA, Ewing SK, Zmuda JM, Wilt TJ, Bauer DC. Correlates and prevalence of prostatitis in a large community-based cohort of older men. Urology 2005;66:964-70.
29. Ross RK, Paganini-Hill A, Henderson BE. The etiology of prostate cancer: what does the epidemiology suggest? Prostate 1983;4:333-44.
30. Niijima T, Koiso K. Incidence of prostatic cancer in Japan and Asia. Scand J Urol Nephrol Suppl 1980;55:17-21.
31. Zhu K, Stanford JL, Daling JR, et al. Vasectomy and prostate cancer: a case-control study in a health maintenance organization. Am J Epidemiol 1996;144:717-22.
32. Rothman I, Stanford JL, Kuniyuki A, Berger RE. Self-report of prostatitis and its risk factors in a random sample of middle-aged men. Urology 2004;64:876-9; discussion 879-80.
33. Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;281:236-7.
34. Nickel JC, Nigro M, Valiquette L, et al. Diagnosis and treatment of prostatitis in Canada. Urology 1998;52:797-802.
35. Moon TD. Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis. Urology 1997;50:543-7.
36. Collins MM, Meigs JB, Barry MJ, Corkery EW, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in the Health Professionals Followup Cohort. J Urol 2002;167:1363-6.
37. http://www.niddk.nih.gov: Executive summary chronic prostatitis workshop. National Institute of Diabetes and Digestive and Kidney Diseases; 1995.
38. McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol 1968;49:347-57.
39. Carver BS, Bozeman CB, Williams BJ, Venable DD. The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol 2003;169:589-91.